"These findings are really striking because we're talking about hundreds of thousands of deaths that don't have to happen,"CDC Director Dr. Tom Frieden said in a news conference. "Many of the heart attacks and strokes that will kill people in the coming year could be prevented by reducing blood pressure and cholesterol, and stopping smoking."
I really can't see a connection between a court verdict and cholesterol, but it makes a nice headline.
Bottom line is really pretty simple, plaques are made of cholesterol. How and why does not concern me since plaques are indeed made of cholesterol. I think the hundreds of thousands of people that have been studied for many, many years and as a result we know that increased levels of cholesterol are linked to an increased risk of heart disease shows me enough.
I'm on statins as well and I don't recall signing anything that requires me to take them for the rest of my life. If my numbers are at my goal and I feel like going without, I will. My numbers are very low right now and I'm OK with it. If I change my mind down the road I'll go off them.
You're doing the right things, talk it over with your doctor. The issue you have is that you are borderline diabetic and diabetics have a much higher risk of heart disease and high cholesterol will increase your risk. It really is up to you so you should get as much information as you can from many sources including your doctor.
No patient had been prescribed a statin for reasons relating to their transplant, but the organs were significantly more likely to have survived in patients taking statins. Seven years after transplantation, more than 80 percent of patients taking statins were still alive, compared with fewer than 70 percent of those not taking statins.
This is just starting to get out, but this finding has been in many discussion in the medical profession over the past few weeks which is now putting pressure on the FDA to remove the statement showing a link on the recent warnings on statins. It is not true and unproven and the FDA looks like they will pull the warning in the upcoming months as they are concerned these hyped up concerns are preventing some from treatment. A systematic review of available evidence (low- to moderate-strength) did not find a link between statin use and adverse cognitive outcomes, according to a study published in Annals of Internal Medicine. Recently, the FDA issued a warning after case reports suggested that statin use may lead to cognitive impairment. Researchers reviewed 25 published randomized, controlled trials and cohort, case-control, and cross-sectional studies evaluating cognition inpatients taking statins. Among statin users, low-quality evidence suggests no increased incidence of Alzheimer disease and no difference in cognitive performance in procedural memory, attention, or motor speed. Moderate-quality evidence suggests no increased incidence of dementia or mild cognitive impairment, nor any changes in cognitive performance. http://www.medicalnewstoday.com/releases/268976.phpView Thread
A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers at the Duke Cancer Institute report. The researchers also found that anti-cholesterol drugs such as statins appear to diminish the effect of this estrogen-like molecule.
Hmmm, you may be confused This is a perfect example of why we need to read the source data and not just the headlines. It took the better part of the first half but I enjoyed reading it all.
This article is about the over use of NNT's, from the source data;
INTERPRETATION: Statin therapy is associated with a slightly increased risk of development of diabetes, but the risk is low both in absolute terms and when compared with the reduction in coronary events. Clinical practice in patients with moderate or high cardiovascular risk or existing cardiovascular disease should not change.And; AUTHORS' CONCLUSIONS: Reductions in all-cause mortality, major vascular events and revascularisations were found with no excess of adverseevents among people without evidence of CVD treated with statins. And;
CONCLUSIONS: Statins have a clear role in primary prevention of CVD mortality and major events. And; CONCLUSION: In patients without established cardiovascular disease but with cardiovascular risk factors, statin use was associated with significantly improved survival and large reductions in the risk of major cardiovascular events.And;
INTERPRETATION: Statin therapy can safely reduce the 5-year incidence of major coronary events, coronary revascularisation, and stroke by about one fifth per mmol/L reduction in LDL cholesterol, largely irrespective of the initial lipid profile or other presenting characteristics. The absolute benefit relates chiefly to an individual's absolute risk of such events and to the absolute reduction in LDL cholesterol achieved. These findings reinforce the need to consider prolonged statin treatment with substantial LDL cholesterol reductions in all patients at high risk of any type of major vascularevent.And; CONCLUSIONS: In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence of major cardiovascular events. (ClinicalTrials.gov number, NCT00239681.)Not sure that Cardiologist explained this to you very well or perhaps you misunderstood his meaning. Back to the football game.View Thread